Page 1640 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1640

Chapter 89  Clinical Approach to Infections in the Compromised Host  1461


               2010 update by the Infectious Diseases Society of America. Clin Infect   23.  Agut H: Deciphering the clinical impact of acute human herpesvirus 6
               Dis 52:431, 2011.                                     (HHV-6) infections. J Clin Virol 52:171, 2011.
            14.  Baskaran ND, Gan GG, Adeeba K: Applying the Multinational Associa-  24.  Kontoyiannis  DP,  Marr  KA,  Park  BJ,  et al:  Prospective  surveillance
               tion for Supportive Care in Cancer risk scoring in predicting outcome of   for  invasive  fungal  infections  in  hematopoietic  stem  cell  transplant
               febrile neutropenia patients in a cohort of patients. Ann Hematol 87:569,   recipients, 2001-2006: Overview of the Transplant-Associated Infection
               2008.                                                 Surveillance Network (TRANSNET) database. Clin Infect Dis 50:1100,
            15.  Paul  M,  Yahav  D,  Bivas  A,  et al:  Anti-pseudomonal  beta-lactams  for   2010.
               the initial, empirical, treatment of febrile neutropenia: Comparison of   25.  Pappas PG, Kauffman CA, Andes D, et al: Clinical practice guidelines
               beta-lactams. Cochrane Database Syst Rev CD005197, 2010.  for  the  management  of  candidiasis:  2009  update  by  the  Infectious
            16.  Blijlevens NM: Neutropenic enterocolitis: Challenges in diagnosis and   Diseases Society of America. Clin Infect Dis 48:535, 2009.
               treatment. Clin Adv Hematol Oncol 7:530, 2009.     26.  Ullmann AJ, Lipton JH, Vesole DH, et al: Posaconazole or fluconazole
            17.  Georgiadou SP, Sipsas NV, Marom EM, et al: The diagnostic value of   for prophylaxis in severe graft-versus-host disease. N Engl J Med 356:347,
               halo and reversed halo signs for invasive mold infections in compromised   2007.
               hosts. Clin Infect Dis 52:1155, 2011.              27.  Wheat LJ, Walsh TJ: Diagnosis of invasive aspergillosis by galactoman-
            18.  O’Grady NP, Alexander M, Burns LA, et al: Guidelines for the preven-  nan antigenemia detection using an enzyme immunoassay. Eur J Clin
               tion of intravascular catheter-related infections. Clin Infect Dis 52:e193,   Microbiol Infect Dis 27:251, 2008.
               2011.                                              28.  Kontoyiannis DP, Lewis RE: How I treat mucormycosis. Blood 118:1224,
            19.  Redelman-Sidi G, Sepkowitz KA: Rapidly growing mycobacteria infec-  2011.
               tion in patients with cancer. Clin Infect Dis 51:434, 2010.  29.  Zell  JA,  Chang  JC:  Neoplastic  fever:  A  neglected  paraneoplastic  syn-
            20.  Kumar  D:  Emerging  viruses  in  transplantation.  Curr  Opin  Infect  Dis   drome. Support Care Cancer 13:877, 2005.
               23:378, 2010.                                      30.  Gulley ML, Tang W: Using Epstein-Barr viral load assays to diagnose,
            21.  Shah JN, Chemaly RF: Management of RSV infections in adult recipi-  monitor, and prevent posttransplant lymphoproliferative disorder. Clin
               ents of hematopoietic stem cell transplantation. Blood 117:2763, 2011.  Microbiol Rev 23:366, 2010.
            22.  Piret  J,  Boivin  G:  Resistance  of  herpes  simplex  viruses  to  nucleoside
               analogues: Mechanisms, prevalence, and management. Antimicrob Agents
               Chemother 55:472, 2011.
   1635   1636   1637   1638   1639   1640   1641   1642   1643   1644   1645